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1. Introduction 
The development of electrochemical sensors has attracted considerable attention as a low-
cost method to the sensitive detection of a variety of pharmaceutical analytes. Since the 
discovery of carbon nanotubes (CNTs) in 1991 [1], research on CNTs has grown rapidly. 
In recent years, CNTs have also been used as electrode modified materials because CNTs 
offer unique advantages including enhanced electronic properties, a large edge 
plane/basal plane ratio, and electron transfer reactions [2]. Thus, CNTs-based sensors 
generally have higher sensitivities in a low concentration or in the complex matrix, lower 
limits of detection, and faster electron transfer kinetics than traditional carbon electrodes. 
Many factors need to be investigated in order to create an optimal CNTs-based sensor. 
Electrode performance can be influenced by the pretreatment of the nanotube, CNTs 
surface modification, the method of electrode attachment, and the addition of electron 
mediators. With the further development of CNTs and nanotechnology, studies on 
preparation, properties and application of CNTs-based modified electrodes have still been 
a hot topic attracting lots of researchers in the world. This article is presented on the 
application of CNTs modified electrode in different pharmaceutical analytes, which 
mainly includes the electrochemical studies on weak basic pharmaceuticals, weak acidic 
pharmaceuticals and other related small biological  molecules. The physical and catalytic 
properties make CNTs ideal for use in sensors. Most notably, CNTs display high electrical 
conductivity, chemical stability, and mechanical strength. 
2. CNTs modified electrode used in analysis of weak basic pharmaceuticals 
Caffeine (3, 7-dihydro-1, 3, 7-trimethyl-1H-purine-2, 6-dione) and theophylline (3, 7-
dihydro-1, 3-dimethyl-1H-purine-2, 6-dione), are two important active alkaloids that are 
widely distributed in beverages and plant products mainly including tea, coffee bean, cocoa 
and cola nuts. They are known to have many pharmacological effects, such as gastric acid 
secretion, diuretic, cardiac stimulant, and stimulant of central nervous system [3]. However, 
appropriate dosing is crucial because of the serious side adverse reactions in the presence of 
high concentrations of these compounds as the risk factors for asthma, kidney malfunction 
and cardiovascular diseases [4]. 
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Nafion, a perfluorinated sulphonated cation exchanger with properties of excellent 
antifouling capacity, chemical inertness and high permeability to cations, has been 
extensively employed as an electrode modifier. CNTs can be homogeneously dispersed in 
Nafion solution because of the hydrophobic side chains and polar head groups of Nafion. 
Nafion/CNTs composite thin film-modified electrodes have their attractive effects in 
electroanalytical applications. Recently, we [5, 6] reported that Nafion/CNTs -modified 
electrode was made, and used as a sensor in the electrochemical determination of caffeine 
and theophylline. This sensor can ameliorate the problems of high overpotential, slow 
electrode reaction, and low sensitivity, which occurs at conventional electrodes.  
Figure 1 displays the characterization of the Nafion/CNTs composite film on the glassy 
carbon electrode (GCE) by using scanning electron microscopy (SEM). It is obvious that the 
Nafion/CNTs composite film was uniformly coated on the electrode surface and formed a 
spaghetti-like porous reticular formation. The special surface morphology offered a much 
larger real surface area than the apparent geometric area.  
 
 
Fig. 1. SEM image of Nafion/CNTs composite film on glassy carbon electrode. 
The experimental results demonstrated that caffeine and theophylline can be effectively 
accumulated at Nafion/CNTs composite film-modified electrode and produce a sensitive 
anodic peak in a 0.01 mol/L H2SO4 medium, respectively (Figure 2). Under the same 
conditions, no anodic peak of caffeine and theophyline was observed at the bare GCE. 
Especially at the Nafion/CNTs nanocomposite -modified electrode, the peak current was 
significantly higher than those at the CNTs/GCE or the Nafion/GCE. The oxidation process 
of caffeine and theophyline at Nafion/CNTs/GCE or Nafion/GCE is irreversible. 
Compared with the Nafion/GCE, the oxidation potential at the Nafion/CNTs/GCE was 
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negatively shifted. This phenomenon may be an evidence of catalytic effect of CNTs toward 
caffeine and theophyline oxidation. The reasons for the notable sensitivity of the 
determination at the Nafion/CNTs/GCE may be summarized as follows:(1) the 
Nafion/CNTs/GCE contains the cation exchanger of Nafion which has selective cation 
exchange enriched ability due to the electrostatic interaction. (2) CNTs display attractive 
characteristics, such as much larger specific surface area, excellent adsorptive ability and 
catalytic ability. Without a doubt, the synergetic functions of Nafion and CNTs make 
contributions to the higher current response [7-12]. 
 
 
 
Fig. 2. Cyclic voltammograms of the Nafion/CNTs-modified GCE (a), Nafion-modified GCE 
(b), the bare GCE (c) in 0.01 mol/L H2SO4 medium containing: A. 3.0 ×10-5 mol/L caffeine; 
scan rate 80 mV/s; B. 2.0 × 10−5 mol/L theophyline; scan rate 100 mV/s.    
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Experiments revealed that the redox peak currents of rutin could be remarkably enhanced 
on AuNPs/en/CNTs/GCE, meaning good electrocatalytic activity for the oxidation of rutin. 
Figure 12 showed the cyclic voltammograms of rutin on different modified electrodes. Rutin 
didn’t display any redox peaks at the bare GCE (a), which demonstrated the weaker 
adsorption and slower electrochemical reaction of rutin on the GCE surface. However, there 
were well-defined redox peaks on the en/CNTs/GCE (b), CNTs/GCE (c) and 
AuNPs/en/CNTs/GCE (d) in 0.1 mol/L phosphate buffer solution (pH 3.5). But the heights 
of the redox peaks were clearly higher in the case of AuNPs/en/CNTs/GCE than that of the 
redox peaks on the en/CNTs/GC or CNTs/GCE. The anodic (Epa) and cathodic peak 
potentials (Epc) were at about 487 mV and 432 mV (vs. SCE), respectively, and the ratio of 
ipa/ipc was about 1.2, which showed that the electrode reaction was almost reversible. Nano-
gold and CNTs can enhance the electron-transfer rate and make more rutin participate in 
the electrochemical reaction due to their accumulation and catalytic ability. 
 
 
Fig. 12. Cyclic voltammograms of 8.0 × 10−5 mol/L rutin in 0.1 mol/L phosphate buffer (pH 
3.5) on the different electrodes: the bare GCE (a), en/CNTs /GCE (b), CNTs/GCE (c) and 
AuNPs/en/CNTs/GCE (d); scan rate 100 mV/s. 
Generally, as the electroactive substance, ascorbic acid (AA) always coexists in the 
Compound Rutin Tablets. The oxidation peak potential of AA is very close to that of rutin, 
which results in poor selectivity determination of AA or rutin in real samples on 
conventional electrodes. Therefore, it is essential to exploit more sensitive, selective and 
simple methods for the segregative determination of AA and rutin. Figure 13 demonstrated 
the cyclic voltammetry (CV) curves of 1.0 × 10−4 mol/L AA (a), the mixture of 2.0 × 10−5 
mol/L rutin and 1.0 × 10−4 mol/L AA (b), 2.0 × 10−5 mol/L rutin (c) and without AA and 
rutin (d) in 0.1 mol/L phosphate buffer solution (pH 3.5) on AuNPs/en/CNTs/GCE. Figure 
13 b showed two anodic peaks at around 186 mV and 487 mV, which were attributed to the 
oxidation of AA and rutin with a 301 mV separation of both peaks, indicating broad enough 
separation for the simultaneous electrochemical determinations of rutin and AA in the 
mixed solution. 
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Fig. 13. Cyclic voltammograms of 1.0 × 10−4 mol/L AA (a), the mixed solution of 1.0 × 10−4 
mol/L AA and 2.0 × 10−5 mol/L rutin (b), 2.0 × 10−5 mol/L rutin (c) and 0.1 mol/L 
phosphate buffer solution (pH 3.5) (d) on the AuNPs/en/CNTs/GCE; scan rate 100 mV/s.   
Under optimized conditions, the anodic peak current was linear to the rutin concentration in 
the range of 4.8 × 10−8 mol/L − 9.6 × 10−7 mol/L. The regression equation was: ipa = 2.3728 
Crutin − 0.1782 (ipa: 10−5A, Crutin: μmol/L, r = 0.9973). The detection limit of 3.2 × 10−8 mol/L 
was obtained. Regeneration and reproducibility are two important characteristics for the 
modified electrode, which should be investigated. The same modified GCE was used for six 
times successive measurements of 2.0 × 10−5 mol/L rutin. After each measurement, the 
surface of the AuNPs/en/CNTs/GCE was regenerated by successively cycling between -
200 mV and 800 mV (vs. SCE) in 0.1 mol/L phosphate buffer solution (pH3.5) for six cycles. 
The relative standard deviation (RSD) of the anodic peak current was 4.3%, which suggested 
good regeneration and reproducibility of the modified electrode. 
This method was used for the determination of rutin in the Compound Rutin Tablets and 
Rutin Tablets. The contents of rutin in the Compound Rutin Tablets and Rutin Tablets were 
calculated to be 20.0 ± 0.87 mg and 19.4 ± 0.54 mg per tablet, respectively (the declared 
content of rutin was 20 mg per tablet). In order to test the accuracy of the proposed method, 
the conventional method of HPLC was employed to determine the contents of rutin in the 
Compound Rutin Tablets and Rutin Tablets (the contents of rutin in the Compound Rutin 
Tablets and Rutin Tablets were 18.9 ± 0.47 mg and 18.1 ± 0.57 mg per tablet, respectively). 
The quantitative results obtained by HPLC were in agreement with the data determined by 
the proposed electrochemical method, indicating that the method was selective and suitable 
for rutin determination in real samples. 
6. Preparation of yttrium hexacyanoferrate/carbon nanotube/Nafion 
nanocomposite film-modified electrode: Application to the electrocatalytic 
oxidation of L-cysteine 
L-cysteine (L-CySH), a sulfur-containing molecule, is one of the most important amino 
acids. It is widely present in many medicines, food and biological tissues, such as cysteine 
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protease, vasopressin and anti-diuretic hormone [40]. It plays a significant role in 
biological systems, playing a role in folding and defolding mechanisms [41]. An 
inadequate dietary intake of L-CySH may cause number of clinical problems, for instance, 
liver damage, skin lesions, and slowed growth [42]. Therefore, the sensitive detection of 
L-CySH is clinically significant. Nevertheless, some traditional methods, such as the 
chromatographic methods, are time-consuming, expensive, and require complicated 
preconcentration, multisolvent extraction and trained technicians. In contrast, 
electrochemical methods are characterized by their simplicity, high sensitivity, good 
stability, low-cost instrumentation, small scale and on-site monitoring [43]. However, 
although L-CySH is an electroactive compound, there are some drawbacks in 
electroanalysis, for example, large overpotential, low sensitivity and sluggish electron-
transfer kinetics at conventional electrodes. These obstacles can result in oxide formation 
and fouling of the electrode surface [44]. To overcome these obstacles, we have 
successfully prepared YHCFNP, and the electrocatalytic oxidation and amperometric 
determination of L-CySH were accomplished at a modified electrode compose of a 
mixture of YHCFNP and CNTs [45].  
As can be seen in figure 14, when YHCFNP and carbon nanotube were mixed together, they 
were uniformly dispersed. In this case, CNTs can be used as the carrier and entanglement 
(diameter: 10 – 20 nm, length: 1–2 μm) to fix YHCFNP on the electrode surface. 
 
 
Fig. 14. Typical SEM images of the mixed YHCFNP and CNTs 
Figure 15 shows the cyclic voltammograms of different electrodes with and without 0.5 
mmol/L L-CySH in 0.1 mol/L PBS (pH 6.82). As figure 15A reveals, at the 
YHCFNP/CNTs/Nafion-modified GCE, there is a pair of well-defined redox peaks at 152 
mV and 250 mV at a scan rate of 20 mV/s without L-cysteine. Under the same conditions, 
there was no redox peak at the CNTs/Nafion-modified GCE and bare GCE.   
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Fig. 15. A. Cyclic voltammograms of different electrodes in 0.1 mol/L PBS (pH 6.82) without 
L-cysteine: YHCFNP/CNTs/Nafion-modified GCE (a), CNTs/Nafion-modified GCE (b), 
GCE (c)；B. Cyclic voltammograms of different electrodes in mol/L PBS (pH 6.82) with 0.5 
m mol/L L-cysteine: YHCFNP/CNTs/Nafion-modified GCE (a), CNTs/Nafion-modified 
GCE (b), CNTs-modified GCE (c), YHCFNP-modified GCE (d), GCE (e). Scan rate 20 mV/s. 
Figure 15 B depicts the cyclic voltammograms of different electrodes with the addition of 
0.5 m mol/L L-CySH in 0.1 mol/L PBS (pH 6.82). L-cysteine produced a weak anodic 
peak at the bare GCE (c), which demonstrates the slower electrochemical reaction of L-
cysteine at the GCE surface. This phenomenon may be related to electrode fouling caused 
by the deposition of this compound and its oxidation products on the electrode surface. 
At the CNTs-modified GCE (c)，there was a well-defined anodic peak，and the peak 
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current was clearly higher than that at the bare GCE. Indeed, in a number of cases, the L-
cysteine molecules under study can interact with carbon nanotube in a way that a well-
polished ‘‘traditional’’ carbon electrode cannot. This phenomenon is evidence of the 
catalytic effect of CNTs toward L-cysteine oxidation. In most cases, the electrocatalytic 
activity of carbon nanotube is attributed to edge plane like-sites/defects, which may occur 
at the ends, and along the tube axis [46]. Recently it has been revealed that additionally, 
metallic impurities remaining from the fabrication processes can be the origin for certain 
analytes [47–49]. Because of the excellent evenly dispersing capacity of Nafion for CNTs, a 
stronger anodic peak of L-CySH was shown at the CNTs/Nafion-modified GCE (b). At 
the YHCFNP-modified GCE (d), a well-defined anodic peak appeared. The peak current 
was obviously higher than that at the bare GCE, which demonstrated that the YHCFNP-
modified GCE can improve the electrochemical reaction of L-cysteine on the electrode 
surface. In addition, a well-defined anodic peak appeared at the YHCFNP/CNTs/Nafion-
modified GCE (a), and the height of the anodic peak was clearly higher than that at the 
CNTs/Nafion-modified GCE. The anodic potential (Epa) was about 570 mV. In contrast, 
the anodic potential at the CNTs/Nafion-modified GCE was 642 mV, indicating a 
negative shift of about 72 mV. The experimental results indicate that the electrooxidation 
of L-CySH is remarkably improved by the YHCFNP/CNTs/Nafion-modified GCE, which 
may result from the high dispersion of YHCFNP/CNTs nanocomposite with high surface 
area and good electronic properties. 
Under the optimum experimental conditions, the electrochemical response to L-cysteine at 
the YHCFNP/CNTs/Nafion-modified GCE was fast (within 4 s). Linear calibration plots 
were obtained over the range of 0.20–11.4 μmol/L with a low detection limit of 0.16 μmol/L. 
The YHCFNP/CNTs/Nafion-modified GCE exhibited several advantages, such as high 
stability and good resistance against interference by ascorbic acid and other oxidizable 
amino acids. 
7. Concluding remarks 
Nowadays, the study of CNTs modified electrode is the forefront subject that offers 
enormous possibilities in pharmaceutical analysis. The facility of the preparation and 
functionalization of CNTs makes them very useful for the development of modified 
electrodes with specific detection of medicine molecules, as well as for the fabrication of 
third generation sensors (no mediator is needed). As far as the modified electrode is 
concerned, the CNTs coated and polymer embedded electrodes are more widely used than 
the CNTs paste electrode and CNTs intercalated electrode in the determination of 
pharmaceutical analysis owing to the different dispersants. Thus, to explore and use the 
materials as dispersants with good and green friendly properties is an important field. 
Moreover, CNTs intermingled with other nonmaterials (such as nano Au particles, nano 
YHCF, etc) were modified on conventional electrodes. These nanocomposites provide a 
synergic effect which results in the improvement in the response property of modified 
electrodes. So, CNTs hybrid with other nanomaterials used as modified material was also an 
important part. In addition, further research on the mechanism of the electrochemical 
reaction between medicine and modified electrode is a very important aspect in relation to 
CNTs modified electrode. Although CNTs modified electrode used in pharmaceutical 
analysis is receiving increasing interest for sensor construction in recent years, the study 
should involve the combination of nanomaterials, analysis and life sciences.   
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